Impact of high dose versus low dose atorvastatin on contrast induced nephropathy in diabetic patients with acute coronary syndrome undergoing early percutaneous coronary intervention
Conclusion No significant difference between high and low doses of atorvastatin in preventing CIN in diabetic patients with normal or mild renal impairment presenting with acute coronary syndrome who underwent early PCI.
Source: The Egyptian Heart Journal - Category: Cardiology Source Type: research
More News: Angioplasty | Atorvastatin Calcium | Cardiology | Cholesterol | Coronary Angioplasty | Diabetes | Endocrinology | Heart | Lipitor | Percutaneous Coronary Intervention | Statin Therapy | Study | Zivast